TVTX logo

Travere Therapeutics (TVTX) Total debt

Annual Total Debt:

$401.58M-$3.20M(-0.79%)
December 31, 2024

Summary

  • As of today (June 16, 2025), TVTX annual total debt is $401.58 million, with the most recent change of -$3.20 million (-0.79%) on December 31, 2024.
  • During the last 3 years, TVTX annual total debt has risen by +$139.60 million (+53.28%).
  • TVTX annual total debt is now -1.45% below its all-time high of $407.49 million, reached on December 31, 2022.

Performance

TVTX Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Quarterly Total Debt:

$400.46M-$1.12M(-0.28%)
March 31, 2025

Summary

  • As of today (June 16, 2025), TVTX quarterly total debt is $400.46 million, with the most recent change of -$1.12 million (-0.28%) on March 31, 2025.
  • Over the past year, TVTX quarterly total debt has dropped by -$3.55 million (-0.88%).
  • TVTX quarterly total debt is now -2.04% below its all-time high of $408.79 million, reached on March 31, 2022.

Performance

TVTX Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

TVTX Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.8%-0.9%
3 y3 years+53.3%-2.0%
5 y5 years+96.0%+93.1%

TVTX Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-1.4%+53.3%-2.0%at low
5 y5-year-1.4%+96.0%-2.0%+93.1%
alltimeall time-1.4%>+9999.0%-2.0%>+9999.0%

TVTX Total debt History

DateAnnualQuarterly
Mar 2025
-
$400.46M(-0.3%)
Dec 2024
$401.58M(-0.8%)
$401.58M(-0.2%)
Sep 2024
-
$402.43M(-0.2%)
Jun 2024
-
$403.23M(-0.2%)
Mar 2024
-
$404.02M(-0.2%)
Dec 2023
$404.78M(-0.7%)
$404.78M(-0.2%)
Sep 2023
-
$405.48M(-0.2%)
Jun 2023
-
$406.17M(-0.2%)
Mar 2023
-
$406.85M(-0.2%)
Dec 2022
$407.49M(+55.5%)
$407.49M(-0.0%)
Sep 2022
-
$407.62M(-0.1%)
Jun 2022
-
$408.17M(-0.2%)
Mar 2022
-
$408.79M(+56.0%)
Dec 2021
$261.99M(+7.4%)
$261.99M(+17.1%)
Sep 2021
-
$223.70M(+1.3%)
Jun 2021
-
$220.86M(+1.3%)
Mar 2021
-
$218.08M(-10.6%)
Dec 2020
$244.03M(+19.1%)
$244.03M(+14.8%)
Sep 2020
-
$212.65M(+1.3%)
Jun 2020
-
$210.01M(+1.3%)
Mar 2020
-
$207.41M(+1.2%)
Dec 2019
$204.86M(-5.8%)
$204.86M(+1.2%)
Sep 2019
-
$202.35M(+1.2%)
Jun 2019
-
$199.89M(-9.1%)
Mar 2019
-
$220.01M(+1.1%)
Dec 2018
$217.55M(+382.6%)
$217.55M(+1.1%)
Sep 2018
-
$215.13M(+373.8%)
Jun 2018
-
$45.40M(+0.4%)
Mar 2018
-
$45.24M(+0.4%)
Dec 2017
$45.08M
$45.08M(+0.4%)
Sep 2017
-
$44.91M(+0.4%)
DateAnnualQuarterly
Jun 2017
-
$44.75M(+0.4%)
Mar 2017
-
$44.58M(+0.4%)
Dec 2016
$44.42M(+1.5%)
$44.42M(+0.4%)
Sep 2016
-
$44.26M(+0.4%)
Jun 2016
-
$44.09M(+0.4%)
Mar 2016
-
$43.93M(+0.4%)
Dec 2015
$43.77M(-47.8%)
$43.77M(+0.0%)
Sep 2015
-
$43.75M(-48.4%)
Jun 2015
-
$84.72M(+0.6%)
Mar 2015
-
$84.24M(+0.6%)
Dec 2014
$83.77M(>+9900.0%)
$83.77M(+0.6%)
Sep 2014
-
$83.29M(+0.6%)
Jun 2014
-
$82.81M(+164.7%)
Mar 2014
-
$31.28M(>+9900.0%)
Dec 2013
$0.00(-100.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(-100.0%)
Dec 2012
$884.80K(+3439.2%)
-
Nov 2012
-
$25.00K(0.0%)
Aug 2012
-
$25.00K(0.0%)
May 2012
-
$25.00K(0.0%)
Feb 2012
-
$25.00K(0.0%)
Feb 2012
$25.00K(0.0%)
-
Nov 2011
-
$25.00K(>+9900.0%)
Aug 2011
-
$0.00(0.0%)
May 2011
-
$0.00(-100.0%)
Feb 2011
$25.00K
$25.00K(>+9900.0%)
Nov 2010
-
$0.00(0.0%)
Aug 2010
-
$0.00(0.0%)
May 2010
-
$0.00

FAQ

  • What is Travere Therapeutics annual total debt?
  • What is the all time high annual total debt for Travere Therapeutics?
  • What is Travere Therapeutics annual total debt year-on-year change?
  • What is Travere Therapeutics quarterly total debt?
  • What is the all time high quarterly total debt for Travere Therapeutics?
  • What is Travere Therapeutics quarterly total debt year-on-year change?

What is Travere Therapeutics annual total debt?

The current annual total debt of TVTX is $401.58M

What is the all time high annual total debt for Travere Therapeutics?

Travere Therapeutics all-time high annual total debt is $407.49M

What is Travere Therapeutics annual total debt year-on-year change?

Over the past year, TVTX annual total debt has changed by -$3.20M (-0.79%)

What is Travere Therapeutics quarterly total debt?

The current quarterly total debt of TVTX is $400.46M

What is the all time high quarterly total debt for Travere Therapeutics?

Travere Therapeutics all-time high quarterly total debt is $408.79M

What is Travere Therapeutics quarterly total debt year-on-year change?

Over the past year, TVTX quarterly total debt has changed by -$3.55M (-0.88%)
On this page